These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10464584)

  • 1. The law, adolescents, and the APOE epsilon 4 genotype: a view from Canada.
    Caulfield TA
    Genet Test; 1999; 3(1):107-13. PubMed ID: 10464584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicolegal, employment, and insurance issues in APOE genotyping and Alzheimer's disease.
    Kapp MB
    Ann N Y Acad Sci; 1996 Dec; 802():139-48. PubMed ID: 8993493
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians' legal duties regarding the use of genetic tests to predict and diagnose Alzheimer disease.
    Kapp MB
    J Leg Med; 2000 Dec; 21(4):445-75. PubMed ID: 11194569
    [No Abstract]   [Full Text] [Related]  

  • 4. Special issues in genetic testing for Alzheimer disease.
    Greely HT
    Genet Test; 1999; 3(1):115-9. PubMed ID: 10464585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for genetic research involving pleiotropic genes: an empirical study of ApoE research.
    Cooper ZN; Nelson RM; Ross LF
    IRB; 2006; 28(5):1-11. PubMed ID: 17152129
    [No Abstract]   [Full Text] [Related]  

  • 6. Legal issues in predictive genetic testing programs.
    Dickens BM
    Alzheimer Dis Assoc Disord; 1994; 8(2):94-101. PubMed ID: 8060611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.
    McConnell LM; Sanders GD; Owens DK
    Genet Test; 1999; 3(1):47-53. PubMed ID: 10464577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
    Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
    Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
    Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease.
    Post SG
    Ann N Y Acad Sci; 1996 Dec; 802():111-9. PubMed ID: 8993490
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion.
    Furman CD; Earnshaw LA; Doukas DJ; Farrer LA; Friedland RP
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):590-5. PubMed ID: 24615498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of Alzheimer disease and the application of molecular tests.
    Tobin SL; Chun N; Powell TM; McConnell LM
    Genet Test; 1999; 3(1):37-45. PubMed ID: 10464576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing and Alzheimer disease: ethical issues for providers and families.
    Cassel CK
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 3():S16-20. PubMed ID: 9876938
    [No Abstract]   [Full Text] [Related]  

  • 14. Legal and ethical issues facing adolescent health care professionals.
    Diaz A; Neal WP; Nucci AT; Ludmer P; Bitterman J; Edwards S
    Mt Sinai J Med; 2004 May; 71(3):181-5. PubMed ID: 15164132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
    Abyad A; al Imad R
    J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.
    Mayeux R; Schupf N
    Am J Public Health; 1995 Sep; 85(9):1280-4. PubMed ID: 7661240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.
    Zick CD; Mathews CJ; Roberts JS; Cook-Deegan R; Pokorski RJ; Green RC
    Health Aff (Millwood); 2005; 24(2):483-90. PubMed ID: 15757934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues.
    Patenaude AF
    Behav Sci Law; 1996; 14(4):393-410. PubMed ID: 9156420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.